Biocon
Search results
Concord Biotech Limited is a R&D driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology. Key Points. Read More. Market Cap ₹ 16,106 Cr. Current Price ₹ 1,542. High / Low ₹ 1,725 / 900. Stock P/E 54.7. Book Value ₹ 146. Dividend Yield 0.57 % ROCE 27.9 %
Jul 1, 2024 · Concord Biotech Share Price: Find the latest news on Concord Biotech Stock Price. Get all the information on Concord Biotech with historic price charts for NSE / BSE.
Concord Biotech Limited (CBL) is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation -based biopharmaceutical active pharmaceutical ingredients (APIs) sold worldwide.
Concord Biotech IPO is a main-board IPO of 20,925,652 equity shares of the face value of ₹1 aggregating up to ₹1,551.00 Crores. The issue is priced at ₹705 to ₹741 per share. The minimum order quantity is 20 Shares. The IPO opens on August 4, 2023, and closes on August 8, 2023.
Concord Biotech Limited is a R&D driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.
Concord Biotech Limited is an R&D based Biotechnology company, having focus on the fermentation, semi-synthetic and synthesis based products. Since its inception in 2000, Concord has recorded...
Aug 4, 2023 · Big bull Rakesh Jhunjhunwala's RARE Enterprises-backed Concord Biotech will be the second public issue in the mainboard segment, opening for subscription this week after SBFC Finance.
Jul 26, 2023 · Ahmedabad-based top biotechnology firm Concord Biotech, which is backed by the late veteran investor Rakesh Jhunjhunwala's firm Rare Enterprises and private equity firm Quadria Capital, is...
Aug 1, 2023 · Concord Biotech IPO: Check issue details, latest GMP, price band, other key key things to know. The Rekha Jhunjhunwala-backed Concord Biotech IPO consists of a pure offer-for-sale (OFS) of...
